KMID : 0191120230380130102
|
|
Journal of Korean Medical Science 2023 Volume.38 No. 13 p.102 ~ p.102
|
|
Baseline Lipoprotein(a) Levels and Long-Term Cardiovascular Outcomes After Acute Myocardial Infarction
|
|
B. Santoni
Cho Kyung-Hoon Hong Young-Joon Kim Min-Chul Sim Doo-Sun Kim Ju-Han Ahn Young-Keun Jeong Myung-Ho
|
|
Abstract
|
|
|
Background : Lipoprotein(a) is a known independent risk factor for atherosclerotic cardiovascular disease. However, the prognostic impact of the baseline lipoprotein(a) levels on long-term clinical outcomes among patients with acute myocardial infarction remain unclear.
Methods : We analyzed 1,908 patients with acute myocardial infarction from November 2011 to October 2015 from a single center in Korea. They were divided into 3 groups according to their baseline lipoprotein(a) levels: groups I (< 30 mg/dL, n = 1,388), II (30?49 mg/dL, n = 263), and III (¡Ã50 mg/dL, n = 257). Three-point major adverse cardiovascular events (a composite of nonfatal myocardial infarction, nonfatal stroke, and cardiac death) at 3 years were compared among the 3 groups.
Results : The patients were followed for 1094.0 (interquartile range, 1,033.8?1,095.0) days, during which a total of 326 (17.1%) three-point major adverse cardiovascular events occurred. Group III had higher rates of three-point major adverse cardiovascular events compared with Group I (23.0% vs. 15.7%; log-rank P = 0.009). In the subgroup analysis, group III had higher rates of three-point major adverse cardiovascular events compared with group I in patients with non-ST-segment elevation myocardial infarction (27.0% vs. 17.1%; log-rank P = 0.006), but not in patients with ST-segment elevation myocardial infarction (14.4% vs. 13.3%; log-rank P = 0.597). However, in multivariable Cox time-to-event models, baseline lipoprotein(a) levels were not associated with an increased incidence of three-point major adverse cardiovascular events, regardless of the type of acute myocardial infarction. Sensitivity analyses in diverse subgroups showed similar findings to those of the main analysis.
Conclusion : Baseline lipoprotein(a) levels in Korean patients with acute myocardial infarction were not independently associated with increased major adverse cardiovascular events at 3 years.
|
|
KEYWORD
|
|
Lipoprotein(a), Myocardial Infarction, Stroke, Death
|
|
FullTexts / Linksout information
|
|
|
|
Listed journal information
|
|
|
|